|
|
|
|
Report No. : |
496628 |
|
Report Date : |
12.03.2018 |
IDENTIFICATION DETAILS
|
Name : |
A. R. LIFE SCIENCES PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
Plot No.150B, Flat No. G-1, Mythreya Apartments, S. R. Nagar,
Hyderabad – 500038, Telangana |
|
Tel. No.: |
91-40-23097679/65907676 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2016 |
|
|
|
|
Date of
Incorporation : |
23.08.2007 |
|
|
|
|
Com. Reg. No.: |
36-055235 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 35.020 Million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U24232TG2007PTC055235 |
|
|
|
|
IEC No.: |
0908008414 |
|
|
|
|
TAN No.: [Tax Deduction & Collection
Account No.] |
Not Available |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAGCA5553K |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer and exporter of a broad range of pharmaceutical intermediates
which are extensively used in various pharmaceutical companies and research
laboratories. (Registered Activity and also Confirmed by management) |
|
|
|
|
No. of Employees
: |
150 (Approximately) |
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2016) |
Current Rating (31.12.2016) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
Not Available |
|
Rating |
Not Available |
|
Rating Explanation |
Not Available |
|
Date |
Not Available |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
INFORMATION PARTED BY (GENERAL DETAILS)
|
Name : |
Mr. Suresh |
|
Designation : |
Purchase Manager |
|
Contact No.: |
91-9985333316 |
|
Date : |
04.04.2017 |
LOCATIONS
|
Registered Office : |
Plot No.150B, Flat No. G-1, Mythreya Apartments, S. R. Nagar, Hyderabad
– 500038, Telangana, India |
|
Tel. No.: |
91-40-23097679/65907676 |
|
Mobile No.: |
91-9985333316 (Mr. Suresh) |
|
Fax No.: |
91-40-23140126 |
|
E-Mail : |
|
|
Website: |
|
|
|
|
|
Factory 1 : |
Plot No. 338, S. V. Co-Operative Industrial Estate, Jeedimetla,
Hyderabad -500055, Telangana, India |
|
Tel. No.: |
91-40-23097679 |
|
Fax No.: |
91-40-23140126 |
|
|
|
|
Factory 2 : |
Plot No. 33, S. V. Co-Operative Industrial Estate, Jeedimetla,
Hyderabad – 500055, Telangana, India |
DIRECTORS
As on 31.03.2016
|
Name : |
Kallam Subba Reddy |
||||||||||||
|
Designation : |
Director |
||||||||||||
|
Address : |
8-3-677/52, SKD Nagar, Yellareddyguda, Hyderabad – 500073, Telangana, India |
||||||||||||
|
Date of Birth/Age : |
10.07.1955 |
||||||||||||
|
Date of Appointment : |
23.08.2007 |
||||||||||||
|
PAN No.: |
ALDPK2606E |
||||||||||||
|
DIN No.: |
01710974 |
||||||||||||
|
Other Directorship:
|
|||||||||||||
|
|
|
||||||||||||
|
Name : |
Kallam Krishna Chaitanya |
||||||||||||
|
Designation : |
Director |
||||||||||||
|
Address : |
8-3-677/52, S.K.D. Nagar, Yellareddyguda, S.R. Nagar, Hyderabad – 500073, Telangana, India |
||||||||||||
|
Date of Birth/Age : |
08.07.1980 |
||||||||||||
|
Date of Appointment : |
23.08.2007 |
||||||||||||
|
PAN No.: |
ARWPK3762G |
||||||||||||
|
DIN No.: |
01711009 |
||||||||||||
|
Other Directorship:
|
|||||||||||||
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 31.03.2016
|
Names of Shareholders |
No. of Shares |
%age
holding |
|
Kallam Subba Reddy |
1709000 |
48.80 |
|
Kallam Krishna Chaitanya |
1109000 |
31.67 |
|
Kallam Basava Kumari |
684000 |
19.53 |
|
Total |
3502000 |
100.00 |
%2012-Mar-2018_files/image019.gif)
Equity Share Break up (Percentage of Total Equity)
As on 30.09.2016
|
Category |
Percentage |
|
Promoters (Individual/Hindu Undivided Family-Indian) |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer and exporter of a broad range of pharmaceutical
intermediates which are extensively used in various pharmaceutical companies
and research laboratories. (Registered Activity and also Confirmed by management) |
||||
|
|
|
||||
|
Products : |
|
||||
|
|
|
||||
|
Brand Names : |
Not Available |
||||
|
|
|
||||
|
Agencies Held : |
Not Available |
||||
|
|
|
||||
|
Exports : |
|
||||
|
Products : |
Finished Goods |
||||
|
Countries : |
|
||||
|
|
|
||||
|
Imports : |
|
||||
|
Products : |
Raw Material |
||||
|
Countries : |
|
||||
|
|
|
||||
|
Terms : |
|
||||
|
Selling : |
Cheque and Others (RTGS) |
||||
|
|
|
||||
|
Purchasing : |
Cheque and Others (RTGS) |
PRODUCTION STATUS NOT AVAILABLE
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Customers : |
Wholesalers, Retailers and Manufacturer
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
No. of Employees : |
150 (Approximately) |
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Bankers : |
|
||||||||||||||||||||||
|
|
|
||||||||||||||||||||||
|
Facilities : |
|
|
Auditors : |
|
|
Name : |
Sudeepthi and Associates Chartered Accountants |
|
Address : |
EWS 221, Road No.3, KPHB Colony, Kukatpally, Hyderabad – 500072,
Telangana, India |
|
Tel. No.: |
91-40-23045514 |
|
E-Mail : |
|
|
Income-tax
PAN of auditor or auditor's firm : |
AYUPK4272G |
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Associates/Subsidiaries : |
Not Divulged |
CAPITAL STRUCTURE
As on 30.09.2016
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
8500000 |
Equity Shares |
INR 10/- each |
INR 85.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
3502000 |
Equity Shares |
INR 10/- each |
INR 35.020
Million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in INR Million]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
|
|
|
|
|
I.
EQUITY AND LIABILITIES |
|
|
|
|
(1)Shareholders' Funds |
|
|
|
|
(a) Share Capital |
35.020 |
35.020 |
35.020 |
|
(b) Reserves &
Surplus |
130.686 |
158.607 |
43.556 |
|
(c) Money received
against share warrants |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
(2) Share Application
money pending allotment |
0.000 |
0.000 |
0.000 |
|
Total Shareholders’ Funds
(1) + (2) |
165.706 |
193.627 |
78.576 |
|
|
|
|
|
|
(3) Non-Current
Liabilities |
|
|
|
|
(a) long-term borrowings |
11.198 |
2.424 |
51.845 |
|
(b) Deferred tax
liabilities (Net) |
10.444 |
0.000 |
2.235 |
|
(c) Other long term
liabilities |
0.000 |
0.000 |
0.000 |
|
(d) long-term provisions |
0.000 |
0.000 |
0.000 |
|
Total Non-current
Liabilities (3) |
21.642 |
2.424 |
54.080 |
|
|
|
|
|
|
(4) Current Liabilities |
|
|
|
|
(a) Short term borrowings |
85.111 |
22.556 |
124.084 |
|
(b) Trade payables |
301.756 |
203.562 |
356.859 |
|
(c) Other current
liabilities |
8.478 |
29.796 |
4.783 |
|
(d) Short-term provisions |
40.993 |
35.752 |
0.000 |
|
Total Current Liabilities
(4) |
436.338 |
291.666 |
485.726 |
|
|
|
|
|
|
TOTAL |
623.686 |
487.717 |
618.382 |
|
|
|
|
|
|
II.
ASSETS |
|
|
|
|
(1) Non-current assets |
|
|
|
|
(a) Fixed Assets |
|
|
|
|
(i) Tangible assets |
95.413 |
29.071 |
194.579 |
|
(ii) Intangible Assets |
0.000 |
0.000 |
0.000 |
|
(iii) Capital
work-in-progress |
0.000 |
0.000 |
0.000 |
|
(iv) Intangible assets
under development |
0.000 |
0.000 |
0.000 |
|
(b) Non-current
Investments |
0.050 |
67.924 |
0.000 |
|
(c) Deferred tax assets
(net) |
0.000 |
0.000 |
0.000 |
|
(d) Long-term Loan and Advances |
3.108 |
22.905 |
0.000 |
|
(e) Other Non-current
assets |
0.000 |
0.000 |
2.523 |
|
Total Non-Current Assets |
98.571 |
119.900 |
197.102 |
|
|
|
|
|
|
(2) Current assets |
|
|
|
|
(a) Current investments |
0.000 |
0.000 |
0.000 |
|
(b) Inventories |
199.013 |
29.938 |
130.179 |
|
(c) Trade receivables |
208.741 |
187.619 |
268.282 |
|
(d) Cash and cash
equivalents |
44.782 |
102.864 |
3.039 |
|
(e) Short-term loans and
advances |
68.838 |
42.159 |
19.772 |
|
(f) Other current assets |
3.741 |
5.237 |
0.008 |
|
Total Current Assets |
525.115 |
367.817 |
421.280 |
|
|
|
|
|
|
TOTAL |
623.686 |
487.717 |
618.382 |
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
|
SALES |
|
|
|
|
|
Income |
805.627 |
1176.671 |
962.758 |
|
|
Other Income |
7.980 |
20.823 |
0.373 |
|
|
TOTAL |
813.607 |
1197.494 |
963.131 |
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
Cost of Materials
Consumed |
678.927 |
1008.090 |
758.279 |
|
|
Changes in inventories of
finished goods, work-in-progress and Stock-in-Trade |
(35.254) |
38.086 |
42.327 |
|
|
Employees benefits
expense |
49.699 |
56.148 |
37.305 |
|
|
Other expenses |
89.981 |
109.845 |
104.732 |
|
|
Extraordinary Items |
0.000 |
(185.033) |
0.000 |
|
|
TOTAL |
783.353 |
1027.136 |
942.643 |
|
|
|
|
|
|
|
Less |
PROFIT/ (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND
AMORTISATION |
30.254 |
170.358 |
20.488 |
|
|
|
|
|
|
|
Less |
FINANCIAL EXPENSES |
9.591 |
6.007 |
21.460 |
|
|
|
|
|
|
|
|
PROFIT / (LOSS) BEFORE
TAX, DEPRECIATION AND AMORTISATION |
20.663 |
164.351 |
(0.972) |
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
14.253 |
17.292 |
24.796 |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS) BEFORE TAX |
6.410 |
147.059 |
(25.768) |
|
|
|
|
|
|
|
Less |
TAX |
3.969 |
34.008 |
(0.036) |
|
|
|
|
|
|
|
|
PROFIT/ (LOSS) AFTER TAX |
2.441 |
113.051 |
(25.732) |
|
|
|
|
|
|
|
|
EARNINGS IN FOREIGN
CURRENCY |
13.494 |
35.656 |
0.000 |
|
|
|
|
|
|
|
|
Earnings / (Loss) Per
Share (INR) |
0.70 |
32.28 |
(7.36) |
CURRENT MATURITIES OF LONG TERM DEBT DETAILS
|
Particulars |
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Current Maturities of Long term debt |
0.898 |
0.813 |
NA |
|
Cash generated from operations |
NA |
NA |
NA |
|
Net cash flows from (used in) operations |
NA |
9.355 |
(32.154) |
|
Net cash flow from operating activity |
NA |
1.756 |
(32.305) |
KEY
RATIOS
|
PARTICULARS |
|
31.03.2016 |
31.03.2015 |
31.03.2014 |
|
Net Profit Margin (PAT / Sales) |
(%) |
0.30 |
9.61 |
(2.67) |
|
|
|
|
|
|
|
Operating Profit Margin (PBIDT/Sales) |
(%) |
3.76 |
14.48 |
2.13 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
1.03 |
30.15 |
(4.17) |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.04 |
0.76 |
(0.33) |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt /Networth) |
|
0.59 |
0.13 |
2.24 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.20 |
1.26 |
0.87 |
FINANCIAL ANALYSIS
[all figures are
in INR Million]
DEBT EQUITY RATIO
|
Particular |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
(INR In Million) |
(INR In Million) |
(INR In Million) |
|
Share Capital |
35.020 |
35.020 |
35.020 |
|
Reserves & Surplus |
43.556 |
158.607 |
130.686 |
|
Money received against
share warrants |
0.000 |
0.000 |
0.000 |
|
Share Application money pending allotment |
0.000 |
0.000 |
0.000 |
|
Net worth |
78.576 |
193.627 |
165.706 |
|
|
|
|
|
|
long-term borrowings |
51.845 |
2.424 |
11.198 |
|
Short term borrowings |
124.084 |
22.556 |
85.111 |
|
Total borrowings |
175.929 |
24.980 |
96.309 |
|
Debt/Equity ratio |
2.239 |
0.129 |
0.581 |
%2012-Mar-2018_files/image020.gif)
YEAR-ON-YEAR GROWTH
|
Year on Year Growth |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
(INR In Million) |
(INR In Million) |
(INR In Million) |
|
Sales |
962.758 |
1176.671 |
805.627 |
|
|
|
22.219 |
(31.533) |
%2012-Mar-2018_files/image021.gif)
NET PROFIT MARGIN
|
Net Profit Margin |
31.03.2014 |
31.03.2015 |
31.03.2016 |
|
|
(INR In Million) |
(INR In Million) |
(INR In Million) |
|
Sales |
962.758 |
1176.671 |
805.627 |
|
Profit/ (Loss) |
(25.732) |
113.051 |
2.441 |
|
|
(2.67%) |
9.61% |
0.30% |
%2012-Mar-2018_files/image022.gif)
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
Yes |
|
8 |
Designation of contact person |
Yes |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
Yes |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
Yes |
|
16 |
No. of employees |
Yes |
|
17 |
Details of sister concerns |
No |
|
18 |
Major suppliers |
Yes |
|
19 |
Major customers |
Yes |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
-- |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last three years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
No |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
No |
|
32 |
Litigations that the firm/promoter
involved in |
-- |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
Yes |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
COMPANY OVERVIEW
The company is based in Hyderabad. The company is the leading
manufacturer and exporter of a broad range of pharmaceutical intermediates
which are extensively used in various pharmaceutical companies and research
laboratories. Using high quality chemicals these intermediates are manufactured
which ensure efficacy and no side effect on human health.
STATE OF COMPANYS
AFFAIRS AND FUTURE OUTLOOK
During the year the company has achieved a net turnover of INR 813.607 Million compared to INR 1197.494 Million of previous year. The company gained a profit of INR 6.410 Million after providing for depreciation on fixed assets of INR 14.253 Million.
SCHEME OF
AMALGAMATION
During the financial year 2015-16, A.R. Life Sciences Private Limited
(the Transferee Company) and Dymes Pharmachem Limited (the transferor) company
vied their Board resolutions dated 11th December, 2015 and 10th
December, 2015 respectively have approved to merge the operations subject to
approved of various regulatory authorities.
Dymes Pharmachem Limited has filed a scheme of amalgamation on 23rd
January, 2016 to merge with Transferee company with effect from appointed date
i.e. 01st October, 2015 with the Hob’ble High Court of Judicature at
Hyderabad for the state of Telangana and the state of Andhra Pradesh pursuant
to the provisions under sections 391 to 394 of the Companies Act, 1956.
Dymes Pharmachem Limited is engaged in the business of Bulk Drug
Manufacturing. The Scheme was approved by the Hon’ble court of Judicature at
Hyderabad for the state of Telangana and state of Andhra Pradesh vide its order
dates 28th July, 2016 under the provision of section 391 to Section
394 of the companies act, 1956. The company has filed a copy of the order with
Registrar of Companies, Andhra Pradesh and Telangana on 21st
September, 2016 (effective date).
And further Transferor Company being wholly owned subsidiary of the
Transferee Company, no shares of the Transferee company shall be allotted in
lieu or exchange of its holding in the Transferor Company and the share capital
of the Transferor Company shall stand cancelled.
UNSECURED LOAN
|
PARTICULARS |
31.03.2016 (INR
in Million) |
31.03.2015 (INR
in Million) |
|
Short-term
borrowings |
|
|
|
Loan from directors |
10.697 |
10.897 |
|
|
|
|
|
Total |
10.697 |
10.897 |
|
Charges Registered |
||||||
|
SNo |
SRN |
Charge Id |
Date of Creation |
Date of Modification |
Amount |
Address |
|
1 |
C76377803 |
10614327 |
02/12/2015 |
- |
62500000.0 |
HDFC BANK HOUSESENAPATI BAPAT MARGLOWER PAREL WEST MUMBAI MAHARASHTRA 400013 INDIA |
|
2 |
C76377662 |
10614326 |
07/10/2015 |
- |
62500000.0 |
HDFC BANK HOUSESENAPATI BAPAT MARGLOWER PAREL WEST MUMBAI MAHARASHTRA 400013 INDIA |
|
3 |
C56431232 |
10137806 |
04/12/2008 |
15/06/2015 |
215000000.0 |
HDFC BANK HOUSESENAPATI BAPAT MARGLOWER PAREL WEST MUMBAI MAHARASHTRA 400013 INDIA |
|
4 |
Y10225997 |
90133192 |
07/05/2004 |
- |
2500000.0 |
SANATHANAGAR HYDERABAD ANDHRA PRADESH 500018 INDIA |
FIXED ASSETS
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 65.08 |
|
|
1 |
INR 89.85 |
|
Euro |
1 |
INR 80.16 |
INFORMATION DETAILS
|
Information
Gathered by : |
SVT |
|
|
|
|
Analysis Done by
: |
NYT |
|
|
|
|
Report Prepared
by : |
JYTK |
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.